JP2023116739A5 - - Google Patents

Download PDF

Info

Publication number
JP2023116739A5
JP2023116739A5 JP2023100171A JP2023100171A JP2023116739A5 JP 2023116739 A5 JP2023116739 A5 JP 2023116739A5 JP 2023100171 A JP2023100171 A JP 2023100171A JP 2023100171 A JP2023100171 A JP 2023100171A JP 2023116739 A5 JP2023116739 A5 JP 2023116739A5
Authority
JP
Japan
Prior art keywords
peptide
hinge region
peptide according
seq
helical domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023100171A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023116739A (ja
Filing date
Publication date
Priority claimed from PCT/US2018/014532 external-priority patent/WO2018136803A1/en
Application filed filed Critical
Publication of JP2023116739A publication Critical patent/JP2023116739A/ja
Publication of JP2023116739A5 publication Critical patent/JP2023116739A5/ja
Pending legal-status Critical Current

Links

JP2023100171A 2017-01-19 2023-06-19 Apoc-ii模倣ペプチド Pending JP2023116739A (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201762448358P 2017-01-19 2017-01-19
US62/448,358 2017-01-19
US201762476535P 2017-03-24 2017-03-24
US201762476531P 2017-03-24 2017-03-24
US62/476,531 2017-03-24
US62/476,535 2017-03-24
PCT/US2018/014532 WO2018136803A1 (en) 2017-01-19 2018-01-19 Apoc-ii mimetic peptides
JP2019539809A JP7353973B2 (ja) 2017-01-19 2018-01-19 Apoc-ii模倣ペプチド

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019539809A Division JP7353973B2 (ja) 2017-01-19 2018-01-19 Apoc-ii模倣ペプチド

Publications (2)

Publication Number Publication Date
JP2023116739A JP2023116739A (ja) 2023-08-22
JP2023116739A5 true JP2023116739A5 (https=) 2023-12-05

Family

ID=62908746

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019539809A Active JP7353973B2 (ja) 2017-01-19 2018-01-19 Apoc-ii模倣ペプチド
JP2023100171A Pending JP2023116739A (ja) 2017-01-19 2023-06-19 Apoc-ii模倣ペプチド

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019539809A Active JP7353973B2 (ja) 2017-01-19 2018-01-19 Apoc-ii模倣ペプチド

Country Status (14)

Country Link
US (2) US11136372B2 (https=)
EP (1) EP3571216A4 (https=)
JP (2) JP7353973B2 (https=)
KR (1) KR102700862B1 (https=)
CN (1) CN110831957B (https=)
AU (1) AU2018210404B2 (https=)
BR (1) BR112019014707A2 (https=)
CA (1) CA3050106A1 (https=)
IL (2) IL268093B2 (https=)
MX (1) MX2019008529A (https=)
NZ (1) NZ755599A (https=)
SG (2) SG10201911974UA (https=)
TW (2) TWI788323B (https=)
WO (1) WO2018136803A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019008529A (es) 2017-01-19 2020-02-07 Us Health Peptidos mimeticos de apolipoproteina c-ii (apoc-ii).
US20240309065A1 (en) * 2021-06-23 2024-09-19 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Short apoc-ii mimetic peptides and methods of use
IL316418A (en) * 2022-05-05 2024-12-01 Us Health Short apolipoprotein E mimetic peptides and methods of use
EP4565251A1 (en) * 2022-08-07 2025-06-11 Protean Bio, Inc. Peptides for beta-cell survival and insulin production

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS6023084B2 (ja) 1979-07-11 1985-06-05 味の素株式会社 代用血液
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4496689A (en) 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
DE3675588D1 (de) 1985-06-19 1990-12-20 Ajinomoto Kk Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
US4791192A (en) 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
US6156727A (en) * 1996-09-05 2000-12-05 Uab Research Foundation Anti-atherosclerotic peptides and a transgenic mouse model of antherosclerosis
AU2002362612B2 (en) 2001-09-28 2007-11-15 Cedars-Sinai Medical Center Prevention and treatment of restenosis by local administration of drug
US7220576B2 (en) * 2002-01-07 2007-05-22 Lifesensors, Inc. Methods and compositions for protein expression and purification
JP2007504285A (ja) * 2003-01-17 2007-03-01 メルク エンド カムパニー インコーポレーテッド N−シクロヘキシルアミノカルボニルベンゼンスルホンアミド誘導体
WO2005058938A2 (en) * 2003-12-15 2005-06-30 The Regents Of The University Of California Helical synthetic peptides that stimulate cellular cholesterol efflux
JPWO2005080348A1 (ja) * 2004-02-19 2007-08-02 萬有製薬株式会社 新規スルホンアミド誘導体
CN101076541A (zh) 2004-07-16 2007-11-21 塔夫茨大学信托人 载脂蛋白a1模拟物及其用途
US8575307B2 (en) * 2005-06-29 2013-11-05 Hadasit Medical Research Services & Development Ltd. Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes
WO2008039843A2 (en) * 2006-09-26 2008-04-03 Lipid Sciences, Inc. Novel peptides that promote lipid efflux
WO2009097584A1 (en) 2008-01-30 2009-08-06 Proteogenix, Inc. Maternal serum biomarkers for detection of pre-eclampsia
WO2009129263A1 (en) * 2008-04-15 2009-10-22 The Government Of The Usa As Represented By The Secretary Of The Department Of Health & Human Serv. Peptides promoting lipid efflux via abca1 and activating a lipoprotein lipase
WO2011040654A1 (ko) 2009-09-30 2011-04-07 서울대학교산학협력단 아포리포프로테인 에이1 모방 펩타이드,및 이를 포함하는 고지혈증 및 이와 관련된 질환 치료제
BR112015010276A2 (pt) * 2012-11-06 2019-10-15 Hoffmann La Roche peptídeos miméticos
MX2019008529A (es) 2017-01-19 2020-02-07 Us Health Peptidos mimeticos de apolipoproteina c-ii (apoc-ii).
EA201991491A1 (ru) 2017-03-24 2019-12-30 Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сервисис Миметические пептиды apoc-ii

Similar Documents

Publication Publication Date Title
JP2023116739A5 (https=)
CA2387184C (en) Cell-permeable peptide inhibitors of the jnk signal transduction pathway
JP2021506814A5 (https=)
JP2003503312A5 (https=)
JP2023156353A5 (https=)
JP2014502252A5 (https=)
CA2370289A1 (en) Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides
US8569235B2 (en) Treatment of kidney disorders with VIP fragments
CA2945838C (en) Modified relaxin b chain peptides
IL192046A (en) Intact and peptide intestinal fragments and methods of use
JP2011518179A5 (https=)
JP2015504052A5 (https=)
JPWO2019156137A5 (https=)
JP2007535910A5 (https=)
AU2016277449B2 (en) Protease-resistant lipidated GLP-1 analogs
AU764218B2 (en) Threonine-containing protegrins
JP2020511425A5 (https=)
JPWO2016063969A1 (ja) ヘマグルチニン結合ペプチド
WO2008050133A2 (en) Inhibition of beta-amyloid aggregation
JP2002539829A5 (https=)
JP2021531246A5 (https=)
JP2002529474A (ja) 高分子量キニノゲン及びそのペプチド類似体による血管形成の抑制
JPWO2021178714A5 (https=)
JP2015506960A5 (https=)
JP2006523181A5 (https=)